Allay Therapeutics raises USD 57.5 million
Biotech firm Allay Therapeutics has raised USD 57.5 million in a Series D funding round co-led by Lightstone Ventures and ClavystBio, with participation from NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures HC, Brandon Capital, IPD Capital, EDBI, and SGInnovate. HSBC Innovation Banking also provided venture debt as part of the deal.